Overview
Loukman Omarjee practices in Rennes, France. Omarjee is rated as a Distinguished expert by MediFind in the treatment of Pseudoxanthoma Elasticum. Their top areas of expertise are Pseudoxanthoma Elasticum, Peripheral Artery Disease, Atherosclerosis, and Calcinosis.
Their clinical research consists of co-authoring 57 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 9 articles and participated in 1 clinical trial in the study of Pseudoxanthoma Elasticum.
Locations
Caen, France
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Peripheral Artery DiseaseOmarjee isDistinguished. Learn about Peripheral Artery Disease.
- Pseudoxanthoma ElasticumOmarjee isDistinguished. Learn about Pseudoxanthoma Elasticum.
- Advanced
- AtherosclerosisOmarjee isAdvanced. Learn about Atherosclerosis.
- CalcinosisOmarjee isAdvanced. Learn about Calcinosis.
- Experienced
- AnginaOmarjee isExperienced. Learn about Angina.
- Antiphospholipid SyndromeOmarjee isExperienced. Learn about Antiphospholipid Syndrome.
- Aortic Valve StenosisOmarjee isExperienced. Learn about Aortic Valve Stenosis.
- Buerger DiseaseOmarjee isExperienced. Learn about Buerger Disease.
- Chronic Myelomonocytic Leukemia (CMML)
- COVID-19Omarjee isExperienced. Learn about COVID-19.